User profiles for C. Lopez-Camacho
César López-CamachoGroup Leader, University of Oxford Verified email at well.ox.ac.uk Cited by 6228 |
[PDF][PDF] Reduced neutralization of SARS-CoV-2 B. 1.617 by vaccine and convalescent serum
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has undergone progressive
change, with variants conferring advantage rapidly becoming dominant lineages, eg, B.…
change, with variants conferring advantage rapidly becoming dominant lineages, eg, B.…
[PDF][PDF] Antibody evasion by the P. 1 strain of SARS-CoV-2
…, R Nutalai, B Wang, C López-Camacho… - Cell, 2021 - cell.com
Terminating the SARS-CoV-2 pandemic relies upon pan-global vaccination. Current
vaccines elicit neutralizing antibody responses to the virus spike derived from early isolates. …
vaccines elicit neutralizing antibody responses to the virus spike derived from early isolates. …
[PDF][PDF] Reduced neutralization of SARS-CoV-2 B. 1.1. 7 variant by convalescent and vaccine sera
…, GC Paesen, J Slon-Campos, C López-Camacho… - Cell, 2021 - cell.com
SARS-CoV-2 has caused over 2 million deaths in little over a year. Vaccines are being
deployed at scale, aiming to generate responses against the virus spike. The scale of the …
deployed at scale, aiming to generate responses against the virus spike. The scale of the …
[HTML][HTML] Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19
…, T Rostron, P Supasa, C Liu, C López-Camacho… - Nature …, 2020 - nature.com
The development of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines
and therapeutics will depend on understanding viral immunity. We studied T cell memory …
and therapeutics will depend on understanding viral immunity. We studied T cell memory …
[PDF][PDF] The antigenic anatomy of SARS-CoV-2 receptor binding domain
…, GC Paesen, J Slon-Campos, C López-Camacho… - Cell, 2021 - cell.com
Antibodies are crucial to immune protection against SARS-CoV-2, with some in emergency
use as therapeutics. Here, we identify 377 human monoclonal antibodies (mAbs) …
use as therapeutics. Here, we identify 377 human monoclonal antibodies (mAbs) …
[HTML][HTML] Evidence of escape of SARS-CoV-2 variant B. 1.351 from natural and vaccine-induced sera
…, R Nutalai, B Wang, GC Paesen, C Lopez-Camacho… - Cell, 2021 - cell.com
The race to produce vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
began when the first sequence was published, and this forms the basis for …
began when the first sequence was published, and this forms the basis for …
[HTML][HTML] Antibody testing for COVID-19: A report from the National COVID Scientific Advisory Panel
…, R Levin, C Liu, C López-Camacho… - Wellcome Open …, 2020 - ncbi.nlm.nih.gov
Background: The COVID-19 pandemic caused> 1 million infections during January-March
2020. There is an urgent need for reliable antibody detection approaches to support diagnosis…
2020. There is an urgent need for reliable antibody detection approaches to support diagnosis…
Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines
…, A Iparraguirre, C Lopez-Camacho… - Blood, The Journal …, 2007 - ashpublications.org
CD8 + T cell-numbers rapidly expand and then contract after exposure to their cognate
antigen. Here we show that the sustained frequencies of transgene product-specific CD8 + T …
antigen. Here we show that the sustained frequencies of transgene product-specific CD8 + T …
[HTML][HTML] A protective Zika virus E-dimer-based subunit vaccine engineered to abrogate antibody-dependent enhancement of dengue infection
…, W Dejnirattisai, BW Jagger, C López-Camacho… - Nature …, 2019 - nature.com
Infections with dengue virus (DENV) and Zika virus (ZIKV) can induce cross-reactive antibody
responses. Two immunodominant epitopes—one to precursor membrane protein and one …
responses. Two immunodominant epitopes—one to precursor membrane protein and one …
[HTML][HTML] Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020
…, N Lim, C Liu, C López-Camacho, C McInally… - …, 2020 - eurosurveillance.org
Background The progression and geographical distribution of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection in the United Kingdom (UK) and elsewhere is …
syndrome coronavirus 2 (SARS-CoV-2) infection in the United Kingdom (UK) and elsewhere is …